By Sriparna Roy April 17 (Reuters) - Eli Lilly's newly launched weight-loss pill was prescribed 1,390 times in the U.S. in ...
The trading gives Waltham-based Kailera a market value of almost $3.1 billion based on the outstanding shares listed in its ...
Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity ...
As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...
Study shows higher rate of child obesity in N.M.
In an approval letter for Foundayo, the FDA said Lilly was required to submit data from the trial by July in order to ...
Hedonic eating as a key driver of overeating and obesity. Doctors explain the complexities of obesity and its association ...
India is an important market for Lilly and we are committed to making orforglipron available to patients globally, including ...
Food and Drug Administration said Eli Lilly is required to conduct post-marketing trials to gauge risks for liver ...
New waist-to-height cutoffs to assess fat mass and obesity predicted the risk of hypertension better than body mass index, ...
The request, which is part of a just-released approval letter for Foundayo, comes amid an intensifying marketing battle ...
Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results